Idexx Laboratories Inc

Basic Materials · In Vitro & In Vivo Diagnostic Substances

—— today

Snapshot

Market cap

—

P/E

—

Forward P/E

—

EPS (TTM)

—

Dividend yield

—

Net margin

24.6%

ROE

66.0%

RSI (14)

—

Beta

—

Short % of float

—

Days to cover

—

52w high

No

Peers in In Vitro & In Vivo Diagnostic Substances

Intellia Therapeutics, Inc

Build a thesis around IDXX

Type a thesis in plain English. AlgoThesis researches it with real data, cites sources, and hands back a tradeable basket.

Open in AlgoThesis →